{
 "edition": "20260828-18",
 "language": "ja",
 "period_start": "2026-08-28T18:00:00+09:00",
 "period_end": "2026-08-28T21:00:00+09:00",
 "page": 4,
 "pages": 4,
 "received_in_period": 319,
 "listed_in_period": 319,
 "description": "2か国・地域のニュースと告知をここでまとめて取得できます：台湾 6ソース 162 件、日本 1ソース 157 件。180分ごとに1号。この時間帯に受信した全ソースの全記事を原文リンク付きで掲載します。",
 "countries": [
  {
   "code": "TW",
   "name": "台湾",
   "items": 162,
   "sources": 6
  },
  {
   "code": "JP",
   "name": "日本",
   "items": 157,
   "sources": 1
  }
 ],
 "number_of_items": 19,
 "items": [
  {
   "id": 2305036,
   "anchor": "n2305036",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305036",
   "title": "ホテルのシャンプーやボディーソープは持ち帰ってもいい？ベテランホテルマネジャーが明かす、チェックアウト時に「これらの品」は安心して持ち帰れる",
   "title_state": "translated",
   "summary": "ホテルの備品を持ち帰っても良いのかについて、業界の慣習と心理的要因を解説。使い切り品は問題ないが、バスローブやタオルの無断持ち出しはコスト増につながる。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "Pan Pacific London"
   ],
   "published_at": "2026-08-28T17:30:00+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "ja",
   "url": "https://www.storm.mg/lifestyle/11159129",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305037,
   "anchor": "n2305037",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305037",
   "title": "「この県市」の県長選は大混戦に　国民党の地元大物が出馬登録書を公開、「もう少し考えさせて」",
   "title_state": "translated",
   "summary": "国民党の彰化県長候補選びを巡る争いが続くなか、落選した前副県長の柯呈枋氏が出馬登録書を公開し、離党して立候補する可能性を示唆。選挙戦はさらに混乱し、地方政界の勢力図が再編される恐れがある。",
   "summary_state": "translated",
   "facts": [],
   "companies": [],
   "published_at": "2026-08-28T17:15:01+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.storm.mg/article/11160128",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305038,
   "anchor": "n2305038",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305038",
   "title": "ベネズエラもOPEC脱退を検討か？アラブ首長国連邦にならい原油生産能力の制限解除、最大の受益者は当然米国",
   "title_state": "translated",
   "summary": "ベネズエラがOPECからの脱退を検討している。これは米国による影響力拡大と原油市場の再編を意味し、国際的なエネルギー情勢に大きな影響を与える可能性がある。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "Chevron",
    "Intel",
    "MP Materials"
   ],
   "published_at": "2026-08-28T17:15:00+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "ja",
   "url": "https://www.storm.mg/article/11160127",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305039,
   "anchor": "n2305039",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305039",
   "title": "台湾株、高値圏で警戒信号。Q4に潜む4つのリスク？専門家が指摘する最大のブラックスワン、高評価のAI株が直撃",
   "title_state": "translated",
   "summary": "AI相場の上昇を背景に、台湾株と米国株は高値圏にある。金融専門家の股人阿勳氏は第四四半期に4つの潜在リスクがあると警告し、最大のブラックスワンは米連邦準備制度理事会（Fed）が再び利上げする可能性で、高評価のAI株に大きな打撃を与えると指摘した。",
   "summary_state": "translated",
   "facts": [],
   "companies": [],
   "published_at": "2026-08-28T17:12:31+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.storm.mg/article/11160141",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305040,
   "anchor": "n2305040",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305040",
   "title": "「次の兆基」の抜け穴を防止！経済部が解釈通達、償還期限前の非公開会社社債の応募者総数は35人以下に",
   "title_state": "translated",
   "summary": "経済部が『下個兆基』関連の私募債乱用を受けて、非公開会社の私募債応募者数を35人までに制限する新解釈を発表。複数回の私募でも合算し、超過企業は新規私募禁止。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "趙姬投資",
    "寄居蟹管理顧問",
    "兆基屋管",
    "宏碁"
   ],
   "published_at": "2026-08-28T17:11:41+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "ja",
   "url": "https://www.storm.mg/article/11160137",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305604,
   "anchor": "n2305604",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305604",
   "title": "「大南方新創展」が開幕！産業発展署が初のテーマ館、30件のAI活用事例で亜湾の実装成果を披露",
   "title_state": "translated",
   "summary": "経済部産業発展署が「大南方新創展」でAI実装成果を発表。27社30件の応用が展示され、80億円超の投資と99億円の産出額を達成。南部AI拠点化が進む。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "鴻海",
    "和碩",
    "友達",
    "晉泰",
    "睿谷科技",
    "威盛電子",
    "台達化",
    "亞聚",
    "台氯"
   ],
   "published_at": "2026-08-28T16:21:00+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "ja",
   "url": "https://www.storm.mg/article/11160185",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305606,
   "anchor": "n2305606",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305606",
   "title": "健康行政で好成績！台南、《康健》調査で6都中2位　黃偉哲市長「限られた資源で最大の効果を発揮」",
   "title_state": "translated",
   "summary": "台南市は《康健》誌の2026年持続可能な健康都市調査で、6都中2位を維持した。黃偉哲市長は、限られた資源で行政効果を最大化し、分野横断的な連携による健康都市政策を推進すると強調した。",
   "summary_state": "translated",
   "facts": [],
   "companies": [],
   "published_at": "2026-08-28T16:18:00+09:00",
   "source_type": "storm",
   "source_name": "風傳媒",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.storm.mg/article/11160183",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305430,
   "anchor": "n2305430",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305430",
   "title": "台湾株週間TOP 15：08/24-08/28の上昇率　安克33.47%、益安17.47%、高端疫苗17.12%―環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "安克16.15",
     "state": "translated",
     "quote": "安克16.15"
    },
    {
     "text": "益安75.30",
     "state": "translated",
     "quote": "益安75.30"
    },
    {
     "text": "高端疫苗65.00",
     "state": "translated",
     "quote": "高端疫苗65.00"
    },
    {
     "text": "共信-KY122.50",
     "state": "translated",
     "quote": "共信-KY122.50"
    },
    {
     "text": "藥華藥1545.00",
     "state": "translated",
     "quote": "藥華藥1545.00"
    },
    {
     "text": "視陽241.50",
     "state": "translated",
     "quote": "視陽241.50"
    }
   ],
   "companies": [
    "安克",
    "益安",
    "高端疫苗",
    "共信-KY",
    "藥華藥",
    "視陽"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89824&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305429,
   "anchor": "n2305429",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305429",
   "title": "法人の週間動向：08/24-08/28の買い越しは高端疫苗7520枚、基亞2196枚、太景*-KY752枚。売り越しは康霈*10881枚、北極星藥業-KY3520枚、晟德3347枚―環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [],
   "companies": [
    "高端疫苗",
    "基亞",
    "太景*",
    "康霈*",
    "北極星藥業",
    "晟德",
    "視陽",
    "保瑞"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89825&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305428,
   "anchor": "n2305428",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305428",
   "title": "08/24-08/28の興櫃株上昇率トップを検証――富禾生醫、瑩碩生技、樂迦再生。人気銘柄は優你康、安立璽榮-KY、安成生技―環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "優你康24455枚",
     "state": "translated",
     "quote": "優你康24455張"
    },
    {
     "text": "安立璽榮-KY11885枚",
     "state": "translated",
     "quote": "安立璽榮-KY11885張"
    },
    {
     "text": "安成生技9358枚",
     "state": "translated",
     "quote": "安成生技9358張"
    },
    {
     "text": "富禾生醫37.85%",
     "state": "translated",
     "quote": "富禾生醫37.85%"
    },
    {
     "text": "瑩碩生技23.34%",
     "state": "translated",
     "quote": "瑩碩生技23.34%"
    },
    {
     "text": "樂迦再生15.81%",
     "state": "translated",
     "quote": "樂迦再生15.81%"
    }
   ],
   "companies": [
    "富禾生醫",
    "瑩碩生技",
    "樂迦再生",
    "優你康",
    "安立璽榮-KY",
    "安成生技"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89826&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305427,
   "anchor": "n2305427",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305427",
   "title": "08/24-08/28のバイオ株週間速報：安克が33.47%上昇、富禾生醫が37.85%で首位―環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "安克（4188）➡️週間上昇率33.47%",
     "state": "translated",
     "quote": "安克(4188)➡️週漲33.47%"
    },
    {
     "text": "益安（6499）➡️週間上昇率17.47%",
     "state": "translated",
     "quote": "益安(6499)➡️週漲17.47%"
    },
    {
     "text": "高端疫苗（6547）➡️週間上昇率17.12%",
     "state": "translated",
     "quote": "高端疫苗(6547)➡️週漲17.12%"
    },
    {
     "text": "富禾生醫（7773）➡️週間上昇率37.85%",
     "state": "translated",
     "quote": "富禾生醫(7773)➡️週漲37.85%"
    },
    {
     "text": "高端疫苗（6547）：7520枚",
     "state": "translated",
     "quote": "高端疫苗(6547)：7520張"
    },
    {
     "text": "基亞（3176）：2196枚",
     "state": "translated",
     "quote": "基亞(3176)：2196張"
    },
    {
     "text": "太景*-KY（4157）：752枚",
     "state": "translated",
     "quote": "太景*-KY(4157)：752張"
    }
   ],
   "companies": [
    "安克",
    "益安",
    "高端疫苗",
    "富禾生醫",
    "瑩碩生技",
    "基亞",
    "太景*-KY"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89827&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305426,
   "anchor": "n2305426",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305426",
   "title": "08/28「バイオ株動向」―環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "欣大健康10%",
     "state": "translated",
     "quote": "欣大健康10%"
    },
    {
     "text": "益安9.93%",
     "state": "translated",
     "quote": "益安9.93%"
    },
    {
     "text": "漢達9.88%",
     "state": "translated",
     "quote": "漢達9.88%"
    },
    {
     "text": "中裕5.87%",
     "state": "translated",
     "quote": "中裕5.87%"
    },
    {
     "text": "威健生技4.93%",
     "state": "translated",
     "quote": "威健生技4.93%"
    },
    {
     "text": "共信-KY4.67%",
     "state": "translated",
     "quote": "共信-KY4.67%"
    },
    {
     "text": "高端疫苗1209枚",
     "state": "translated",
     "quote": "高端疫苗1209張"
    },
    {
     "text": "太景*-KY400枚",
     "state": "translated",
     "quote": "太景*-KY400張"
    }
   ],
   "companies": [
    "康霈",
    "昱展新藥",
    "欣大健康",
    "益安",
    "漢達",
    "中裕",
    "威健生技",
    "共信-KY",
    "高端疫苗",
    "太景*-KY"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89832&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305425,
   "anchor": "n2305425",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305425",
   "title": "晶碩(6491)、9/4に統一證券主催の投資フォーラムに招待される－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "事実発生日 115/09/04",
     "state": "translated",
     "quote": "事實發生日 115/09/04"
    }
   ],
   "companies": [
    "晶碩",
    "統一證券"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89829&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305424,
   "anchor": "n2305424",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305424",
   "title": "康霈(6919)の減量薬CBL-514、米FDAに提出した治験変更申請がFDA INDの30日間の審査期間を通過－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "FDA IND 30日間の審査期間",
     "state": "translated",
     "quote": "FDA IND 30天審閱期"
    }
   ],
   "companies": [
    "康霈",
    "FDA"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89833&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305423,
   "anchor": "n2305423",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305423",
   "title": "健喬(4114)、第15回自己株式買い戻し期間が満了、計2,935枚、平均取得価格29.97元－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [],
   "companies": [
    "健喬",
    "環球生技月刊"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89834&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305422,
   "anchor": "n2305422",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305422",
   "title": "優你康(4150)、115年7月末の自己決算で流動比率96.75%、当座比率55.12%、負債比率66.23%－環球生技月刊",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [],
   "companies": [
    "優你康",
    "環球生技月刊"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89835&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305421,
   "anchor": "n2305421",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305421",
   "title": "昱展新藥(6785)收到阿拉伯聯合大公國專利核准「LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS」 -環球生技月刊",
   "title_state": "original",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "6785",
     "state": "translated",
     "quote": "6785"
    }
   ],
   "companies": [
    "昱展新藥",
    "阿拉伯聯合大公國"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=89836&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305389,
   "anchor": "n2305389",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305389",
   "title": "慢性疾患の薬を長期間服用することに悩んでいませんか？天然植物の補助的な可能性を探る",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "今年五十二歳",
     "state": "translated",
     "quote": "今年五十二歲"
    }
   ],
   "companies": [
    "電子公司"
   ],
   "published_at": "2026-08-28T17:28:29+09:00",
   "source_type": "careonline",
   "source_name": "照護線上",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.careonline.com.tw/2026/08/202608281600.html",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 2305474,
   "anchor": "n2305474",
   "permalink": "https://ainews.idaeo.ai/180m/20260828-18/index-ja-p4.html#n2305474",
   "title": "【会務速報】本会、第14期第3回広報委員会を開催",
   "title_state": "translated",
   "summary": "",
   "summary_state": "none",
   "facts": [
    {
     "text": "第14回",
     "state": "translated",
     "quote": "第14屆"
    },
    {
     "text": "第3回",
     "state": "translated",
     "quote": "第3次"
    },
    {
     "text": "115年",
     "state": "translated",
     "quote": "115年"
    },
    {
     "text": "8月",
     "state": "translated",
     "quote": "8月"
    },
    {
     "text": "25日",
     "state": "translated",
     "quote": "25日"
    }
   ],
   "companies": [
    "中華民國醫師公會全國聯合會"
   ],
   "published_at": "2026-08-28T01:00:00+09:00",
   "source_type": "tma",
   "source_name": "中華民國醫師公會全國聯合會",
   "country": "TW",
   "country_name": "台湾",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.tma.tw/meeting/meeting_info.asp?/14709.html",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}